List of Tables
Table 1. Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharmaceutical Marijuana (MMJ) Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharmaceutical Marijuana (MMJ) Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) of Key Manufacturers (2020-2025)
Table 5. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharmaceutical Marijuana (MMJ) Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharmaceutical Marijuana (MMJ) Average Price (US$/KG) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharmaceutical Marijuana (MMJ), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Product Type & Application
Table 12. Global Key Manufacturers of Pharmaceutical Marijuana (MMJ), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Marijuana (MMJ) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Marijuana (MMJ) as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Marijuana (MMJ) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharmaceutical Marijuana (MMJ) Sales by Region (2020-2025) & (Kiloton)
Table 18. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical Marijuana (MMJ) Sales by Region (2026-2031) & (Kiloton)
Table 20. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2026-2031)
Table 21. Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2020-2025)
Table 23. Global Pharmaceutical Marijuana (MMJ) Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2026-2031)
Table 25. North America Pharmaceutical Marijuana (MMJ) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharmaceutical Marijuana (MMJ) Sales by Country (2020-2025) & (Kiloton)
Table 27. North America Pharmaceutical Marijuana (MMJ) Sales by Country (2026-2031) & (Kiloton)
Table 28. North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharmaceutical Marijuana (MMJ) Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2020-2025) & (Kiloton)
Table 32. Europe Pharmaceutical Marijuana (MMJ) Sales by Country (2026-2031) & (Kiloton)
Table 33. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharmaceutical Marijuana (MMJ) Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Marijuana (MMJ) Sales by Region (2020-2025) & (Kiloton)
Table 37. Asia Pacific Pharmaceutical Marijuana (MMJ) Sales by Region (2026-2031) & (Kiloton)
Table 38. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharmaceutical Marijuana (MMJ) Sales by Country (2020-2025) & (Kiloton)
Table 42. Latin America Pharmaceutical Marijuana (MMJ) Sales by Country (2026-2031) & (Kiloton)
Table 43. Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmaceutical Marijuana (MMJ) Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2020-2025) & (Kiloton)
Table 47. Middle East and Africa Pharmaceutical Marijuana (MMJ) Sales by Country (2026-2031) & (Kiloton)
Table 48. Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Type (2020-2025)
Table 51. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Type (2026-2031)
Table 52. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2020-2025)
Table 53. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Type (2026-2031)
Table 54. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2020-2025)
Table 57. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Type (2026-2031)
Table 58. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Type (2020-2025)
Table 59. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Type (2026-2031)
Table 60. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Application (2020-2025)
Table 61. Global Pharmaceutical Marijuana (MMJ) Sales (Kiloton) by Application (2026-2031)
Table 62. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2020-2025)
Table 63. Global Pharmaceutical Marijuana (MMJ) Sales Market Share by Application (2026-2031)
Table 64. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharmaceutical Marijuana (MMJ) Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2020-2025)
Table 67. Global Pharmaceutical Marijuana (MMJ) Revenue Market Share by Application (2026-2031)
Table 68. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Application (2020-2025)
Table 69. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Application (2026-2031)
Table 70. Canopy Growth Corporation Company Information
Table 71. Canopy Growth Corporation Description and Business Overview
Table 72. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 73. Canopy Growth Corporation Pharmaceutical Marijuana (MMJ) Product
Table 74. Canopy Growth Corporation Recent Developments/Updates
Table 75. GW Pharmaceuticals, plc Company Information
Table 76. GW Pharmaceuticals, plc Description and Business Overview
Table 77. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 78. GW Pharmaceuticals, plc Pharmaceutical Marijuana (MMJ) Product
Table 79. GW Pharmaceuticals, plc Recent Developments/Updates
Table 80. Aurora Cannabis, Inc. Company Information
Table 81. Aurora Cannabis, Inc. Description and Business Overview
Table 82. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 83. Aurora Cannabis, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 84. Aurora Cannabis, Inc. Recent Developments/Updates
Table 85. Aphria, Inc. Company Information
Table 86. Aphria, Inc. Description and Business Overview
Table 87. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 88. Aphria, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 89. Aphria, Inc. Recent Developments/Updates
Table 90. MedReleaf Corporation Company Information
Table 91. MedReleaf Corporation Description and Business Overview
Table 92. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 93. MedReleaf Corporation Pharmaceutical Marijuana (MMJ) Product
Table 94. MedReleaf Corporation Recent Developments/Updates
Table 95. Insys Therapeutics, Inc. Company Information
Table 96. Insys Therapeutics, Inc. Description and Business Overview
Table 97. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 98. Insys Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 99. Insys Therapeutics, Inc. Recent Developments/Updates
Table 100. CanniMed Therapeutics, Inc. Company Information
Table 101. CanniMed Therapeutics, Inc. Description and Business Overview
Table 102. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 103. CanniMed Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 104. CanniMed Therapeutics, Inc. Recent Developments/Updates
Table 105. Cara Therapeutics, Inc. Company Information
Table 106. Cara Therapeutics, Inc. Description and Business Overview
Table 107. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 108. Cara Therapeutics, Inc. Pharmaceutical Marijuana (MMJ) Product
Table 109. Cara Therapeutics, Inc. Recent Developments/Updates
Table 110. United Cannabis Corporation Company Information
Table 111. United Cannabis Corporation Description and Business Overview
Table 112. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2020-2025)
Table 113. United Cannabis Corporation Pharmaceutical Marijuana (MMJ) Product
Table 114. United Cannabis Corporation Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Pharmaceutical Marijuana (MMJ) Distributors List
Table 118. Pharmaceutical Marijuana (MMJ) Customers List
Table 119. Pharmaceutical Marijuana (MMJ) Market Trends
Table 120. Pharmaceutical Marijuana (MMJ) Market Drivers
Table 121. Pharmaceutical Marijuana (MMJ) Market Challenges
Table 122. Pharmaceutical Marijuana (MMJ) Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Marijuana (MMJ)
Figure 2. Global Pharmaceutical Marijuana (MMJ) Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Marijuana (MMJ) Market Share by Type: 2024 & 2031
Figure 4. THC-dominant Product Picture
Figure 5. CBD-dominant Product Picture
Figure 6. Balanced THC & CBD Product Picture
Figure 7. Global Pharmaceutical Marijuana (MMJ) Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Pharmaceutical Marijuana (MMJ) Market Share by Application: 2024 & 2031
Figure 9. Cancer
Figure 10. Arthritis
Figure 11. Migraine
Figure 12. Epilepsy
Figure 13. Others
Figure 14. Global Pharmaceutical Marijuana (MMJ) Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharmaceutical Marijuana (MMJ) Market Size (2020-2031) & (US$ Million)
Figure 16. Global Pharmaceutical Marijuana (MMJ) Sales (2020-2031) & (Kiloton)
Figure 17. Global Pharmaceutical Marijuana (MMJ) Average Price (US$/KG) & (2020-2031)
Figure 18. Pharmaceutical Marijuana (MMJ) Report Years Considered
Figure 19. Pharmaceutical Marijuana (MMJ) Sales Share by Manufacturers in 2024
Figure 20. Global Pharmaceutical Marijuana (MMJ) Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Pharmaceutical Marijuana (MMJ) Players: Market Share by Revenue in Pharmaceutical Marijuana (MMJ) in 2024
Figure 22. Pharmaceutical Marijuana (MMJ) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Pharmaceutical Marijuana (MMJ) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2020-2031)
Figure 25. North America Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2020-2031)
Figure 26. United States Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2020-2031)
Figure 29. Europe Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2020-2031)
Figure 30. Germany Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Pharmaceutical Marijuana (MMJ) Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Pharmaceutical Marijuana (MMJ) Revenue Market Share by Region (2020-2031)
Figure 37. China Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2020-2031)
Figure 47. Latin America Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Pharmaceutical Marijuana (MMJ) Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Pharmaceutical Marijuana (MMJ) Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Pharmaceutical Marijuana (MMJ) Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Pharmaceutical Marijuana (MMJ) by Type (2020-2031)
Figure 57. Global Revenue Market Share of Pharmaceutical Marijuana (MMJ) by Type (2020-2031)
Figure 58. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Type (2020-2031)
Figure 59. Global Sales Market Share of Pharmaceutical Marijuana (MMJ) by Application (2020-2031)
Figure 60. Global Revenue Market Share of Pharmaceutical Marijuana (MMJ) by Application (2020-2031)
Figure 61. Global Pharmaceutical Marijuana (MMJ) Price (US$/KG) by Application (2020-2031)
Figure 62. Pharmaceutical Marijuana (MMJ) Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed